Page last updated: 2024-09-03

dansylsarcosine and oxyphenbutazone

dansylsarcosine has been researched along with oxyphenbutazone in 2 studies

Compound Research Comparison

Studies
(dansylsarcosine)
Trials
(dansylsarcosine)
Recent Studies (post-2010)
(dansylsarcosine)
Studies
(oxyphenbutazone)
Trials
(oxyphenbutazone)
Recent Studies (post-2010) (oxyphenbutazone)
40151,23714824

Protein Interaction Comparison

ProteinTaxonomydansylsarcosine (IC50)oxyphenbutazone (IC50)
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium berghei12.5
caspase recruitment domain family, member 15Homo sapiens (human)6.633
receptor-interacting serine/threonine-protein kinase 2 isoform 1Homo sapiens (human)6.633

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cittanova, N; Desfosses, B; Urbach, W; Waks, M1
Kosa, T; Maruyama, T; Nishi, K; Otagiri, M; Sakai, N; Suenaga, A; Watanabe, H; Yonemura, N1

Other Studies

2 other study(ies) available for dansylsarcosine and oxyphenbutazone

ArticleYear
Ligand binding at membrane mimetic interfaces. Human serum albumin in reverse micelles.
    European journal of biochemistry, 1991, Jul-01, Volume: 199, Issue:1

    Topics: Circular Dichroism; Dansyl Compounds; Hemin; Humans; Ligands; Micelles; Oxidation-Reduction; Oxyphenbutazone; Sarcosine; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tryptophan

1991
Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface.
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:11

    Topics: Animals; Circular Dichroism; Dansyl Compounds; Dogs; Humans; Ligands; Membranes; Micelles; Oxyphenbutazone; Protein Binding; Rabbits; Rats; Sarcosine; Serum Albumin; Species Specificity; Spectrometry, Fluorescence

2007